Corporate Governance

Our Committees

Audit Committee

Joanne Shaw chairs the Audit Committee. Its other members are Deborah Kemp, David Wilton, and Richard Gray. All members are fully independent. Joanne has a wealth of experience in senior finance roles within the Healthcare sector. The Board considers that members of the Audit Committee have recent and relevant financial expertise, and that the Committee as a whole has competence relevant to the sector in which the Company operates.

The Audit Committee’s duties primarily concern financial reporting, internal control and risk management systems, whistleblowing procedures and internal audit and external audit arrangements (including auditor independence).

Audit and Risk Committee

Joanne Shaw chairs the Audit and Risk Committee. Its other members are Deborah Kemp, Richard Gray, Helen Keays and Jane Bednall. All members are fully independent. Joanne has a wealth of experience in senior finance roles within the Healthcare sector. The Board considers that members of the Audit and Risk Committee have recent and relevant financial expertise, and that the Committee as a whole has competence relevant to the sector in which the Company operates.

The Audit and Risk Committee’s duties primarily concern financial reporting, internal control and risk management systems, whistleblowing procedures and internal audit and external audit arrangements (including auditor independence).

Remuneration Committee

Deborah Kemp chairs the Remuneration Committee with Helen Keays elected as chair designate, with effect from 1 July 2026. Its other members are Joanne Shaw, Richard Gray and Jane Bednall who are all fully independent, and David Wilton.

The Remuneration Committee has delegated responsibility for designing and determining remuneration for the Chair, the Executive Directors and the next level of senior management, as well as the Company Secretary.

Nomination Committee

David Wilton chairs the Nomination Committee. Its other members are Richard Gray, Deborah Kemp, Joanne Shaw, Helen Keays and Jane Bednall who are all fully independent.

The Nomination Committee is responsible for reviewing the structure, size and composition, including skills, independence, knowledge and experience, of the Board. It is also responsible for the co-ordination of the annual evaluation of the performance of the Board and of its Committees, and for ensuring appropriate succession plans are in place. All Directors engage in the internal evaluation and appropriate action is taken in light of the assessment. The Committee is responsible for making recommendations to the Board on all Board appointments and on the succession plans for both Executive Directors and Non-Executive Directors.

Disclosure Committee

The Disclosure Committee supports the board by ensuring compliance with the company’s market disclosure obligations. It is responsible for ensuring that information requiring disclosure under the UK Market Abuse Regulation, the Disclosure Guidance and Transparency Rules, and the UK Listing Rules is identified, reviewed, and communicated appropriately.